These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18457524)

  • 21. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
    Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
    J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible alternative treatments of Alzheimer's disease.
    Robertson DS
    Med Hypotheses; 2004; 63(6):1083-4. PubMed ID: 15504581
    [No Abstract]   [Full Text] [Related]  

  • 24. [New knowledge about amyloid can result in new treatment of Alzheimer disease].
    Jönhagen ME
    Lakartidningen; 2005 Oct 24-30; 102(43):3104-5. PubMed ID: 16302503
    [No Abstract]   [Full Text] [Related]  

  • 25. PBT-1 Prana Biotechnology.
    Huckle R
    Curr Opin Investig Drugs; 2005 Jan; 6(1):99-107. PubMed ID: 15675609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unraveling the tangled brain of Alzheimer's.
    Wolfson W
    Chem Biol; 2008 Feb; 15(2):89-90. PubMed ID: 18291309
    [No Abstract]   [Full Text] [Related]  

  • 27. Amyloid beta-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer's brain.
    Aoki M; Volkmann I; Tjernberg LO; Winblad B; Bogdanovic N
    Neuroreport; 2008 Jul; 19(11):1085-9. PubMed ID: 18596605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages.
    Tolón RM; Núñez E; Pazos MR; Benito C; Castillo AI; Martínez-Orgado JA; Romero J
    Brain Res; 2009 Aug; 1283():148-54. PubMed ID: 19505450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of kinesin light-chain 1 gene expression by acetyl-L-carnitine: therapeutic possibility in Alzheimer's disease.
    Traina G; Federighi G; Brunelli M
    Neurochem Int; 2008 Dec; 53(6-8):244-7. PubMed ID: 18761385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 11C-labelled PIB analogues as potential tracer agents for in vivo imaging of amyloid beta in Alzheimer's disease.
    Serdons K; Verduyckt T; Vanderghinste D; Borghgraef P; Cleynhens J; Van Leuven F; Kung H; Bormans G; Verbruggen A
    Eur J Med Chem; 2009 Apr; 44(4):1415-26. PubMed ID: 18992967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A system for the brain-enhanced delivery of estradiol: an assessment of its potential for the treatment of Alzheimer's disease and stroke.
    Simpkins JW; Rabbani O; Shi J; Panickar KS; Green PS; Day AL
    Pharmazie; 1998 Aug; 53(8):505-11. PubMed ID: 9741059
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic approaches for Alzheimer's disease.
    Jahnke U
    IDrugs; 2008 Jan; 11(1):4-6. PubMed ID: 18175250
    [No Abstract]   [Full Text] [Related]  

  • 33. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology.
    Schilling S; Zeitschel U; Hoffmann T; Heiser U; Francke M; Kehlen A; Holzer M; Hutter-Paier B; Prokesch M; Windisch M; Jagla W; Schlenzig D; Lindner C; Rudolph T; Reuter G; Cynis H; Montag D; Demuth HU; Rossner S
    Nat Med; 2008 Oct; 14(10):1106-11. PubMed ID: 18836460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comment on "The emerging roles of cystatins in Alzheimer's disease". DOI 10.1002/bies.200900012.
    Bernstein HG; Malone TM
    Bioessays; 2009 Sep; 31(9):1004-5. PubMed ID: 19676077
    [No Abstract]   [Full Text] [Related]  

  • 37. Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden.
    Kellner A; Matschke J; Bernreuther C; Moch H; Ferrer I; Glatzel M
    Ann Neurol; 2009 Jan; 65(1):24-31. PubMed ID: 19194878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive-performance recovery of Alzheimer's disease model mice by modulation of early soluble amyloidal assemblies.
    Frydman-Marom A; Rechter M; Shefler I; Bram Y; Shalev DE; Gazit E
    Angew Chem Int Ed Engl; 2009; 48(11):1981-6. PubMed ID: 19035593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decorated plaques in Alzheimer's disease.
    Tabira T
    Ann Neurol; 2009 Jan; 65(1):4-6. PubMed ID: 19194874
    [No Abstract]   [Full Text] [Related]  

  • 40. Update on amyloid-beta homeostasis markers for sporadic Alzheimer's disease.
    Zetterberg H
    Scand J Clin Lab Invest; 2009; 69(1):18-21. PubMed ID: 19199126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.